This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Marijuana ETF Down 9% in Past Month: Time to Enter the Space?
by Sanghamitra Saha
Growing global acceptance, increasing legalization and beaten-down prices open up room for marijuana ETF investing.
The Zacks Analyst Blog Highlights: Constellation Brand, Canopy Growth, Aurora Cannabis, Cronos and Tilray
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Constellation Brand, Canopy Growth, Aurora Cannabis, Cronos and Tilray
4 Marijuana Stocks to Watch in 2019
by Tirthankar Chakraborty
According to Arcview Market Research and BDS Analytics, global consumer marijuana outlays are estimated to climb 38% to $16.9 billion this year, up from a projected $12.2 billion last year, $9.5 billion in 2017, and $6.9 billion in 2016.
Constellation Makes Big Cannabis Bet
by Daniel Laboe
Constellation Brands have been continuously adding to their stake in Canopy Growth (CGC), which is the leading player in the Canadian cannabis market. STZ just added another $4 billion investment in August bringing its total stake in Canopy to 38% ownership.
Short Sellers and Easing Rules Boost Pot ETF Higher
by Sweta Killa
Along with easing rules, short-selling of the stocks led to the spike in the pot ETF.
Constellation Brands (STZ) Q4 Earnings & Sales Beat Estimates
by Zacks Equity Research
Constellation Brands' (STZ) fourth-quarter fiscal 2019 results gain from solid portfolio depletions and market share growth in the beer business. However, the wine & spirits business remains a weak spot.
Marijuana Banking, IPOs & Weed Votes: Will Hemp Grow Higher? (Revised)
by Nitish Marwah
Experts are of the view that the marijuana industry would generate as much as $5 billion in annual revenues over the next two years.
Marijuana Banking, IPOs & Weed Votes: Will Hemp Grow Higher?
by Nitish Marwah
Experts are of the view that the marijuana industry would generate as much as $5 billion in annual revenues over the next two years.
Factors Likely to Shape Constellation Brands (STZ) Q4 Earnings
by Zacks Equity Research
Constellation Brands (STZ) gains from constant brand-building efforts, acquisitions and e-commerce initiatives. However, a soft outlook for fiscal 2019 and higher costs are concerning.
Marijuana ETF Outperforms in Q1: 6 Stocks Leading the Rally
by Sweta Killa
Though most of the stocks in the marijuana ETF portfolio delivered strong returns, a few were the real stars, soaring more than 60% in the first quarter.
US Marijuana Industry to Flourish in 2019: Who Gains?
by Nalak Das
Legalization has long been considered a boon for the marijuana industry.
Big Week for Data and News Leaves Stocks Broadly Unchanged
by David Borun
With a large amount of conflicting information, the equity markets barely budged throughout the week
Marijuana Stocks and ETFs: Risks and Rewards
by Neena Mishra
Pot stocks are soaring again. To learn more about risks and rewards of investing in marijuana stocks and ETFs, check out this Exploring ETFs video.
What Investors Need to Know About Investing in Marijuana Stocks
by Benjamin Rains
Let's look at what investors need to know about the marijuana industry and how to invest in the future of pot.
ETFs and Stocks to Tap the Marijuana Boom
by Sweta Killa
First it was bitcoin that made investors go on a mad rush, and today, it's marijuana. Now that legalization is steadily gaining traction across the U.S., more investors than ever before are looking for ways to cash in.
Tilray's Deal to Buy Hemp Food Maker Bolsters Marijuana ETF
by Sweta Killa
Tilray's deal to acquire the hemp food maker Manitoba Harvest has bolstered the outlook of the already high-flying marijuana ETF.
Forget Mixed Pot Earnings; Bet on ETF on Growth Prospects
by Sanghamitra Saha
Key marijuana companies came up with mixed earnings, but that should not hurt the pot ETF.
The Zacks Analyst Blog Highlights: GW, Innovative, KushCo, Canopy and Constellation
by Zacks Equity Research
The Zacks Analyst Blog Highlights: GW, Innovative, KushCo, Canopy and Constellation
4 Marijuana Stocks to Watch in 2019
by Tirthankar Chakraborty
Marijuana stocks may not have had a stellar year in 2018. But, this year could easily bring better news as things continue to expand and more new marijuana markets open up.
Canopy Growth Corporation (CGC) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Canopy Growth Corporation (CGC) delivered earnings and revenue surprises of -346.67% and -4.91%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
4 Reasons Why Marijuana Stocks & ETFs Could Be on a High in 2019
by Sanghamitra Saha
Marijuana stocks and related ETFs caught investors' attention last year, courtesy of its mysterious rally in mid-2018 on Canada's legalization of recreational marijuana in October. Let's take a look at whether the space will be able to maintain its rally in 2019.
Canopy Growth Corporation (CGC) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
Canopy Growth Corporation (CGC) delivered earnings and revenue surprises of -53.33% and -4.91%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Why Marijuana ETFs are on a High in 2019
by Sweta Killa
After being beaten down in the final quarter of 2018, pot stocks staged a nice comeback at the start of this year on the renewed appeal for riskier assets. Here's why ETFs are riding high this year.
Is the Options Market Predicting a Spike in Canopy Growth (CGC) Stock?
by Zacks Equity Research
Investors need to pay close attention to Canopy Growth (CGC) stock based on the movements in the options market lately.
4 Best Marijuana Stocks to Play the Green Rush
by Zacks Equity Research
Whether its eating a gooey, chocolatey brownie or taking a few hits off a freshly rolled joint, it???s common knowledge that a lot of people like to get high. Many investors, however, have yet to "light up." What are the best marijuana stocks out there right now?